Unison Pharmaceuticals Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Glimison-VM 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Glimison-VM 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimison-VM 2 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimison-VM 2 Tablet SR.
Glimison-VM 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimison-VM 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimison-VM 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly.
Glimison-VM 2 Tablet SR is a combination medication that includes Glimepiride, Metformin, and Voglibose. This formulation is used to treat Type 2 diabetes mellitus (DM). It works by improving blood glucose levels in adults when taken alongside a healthy diet and regular exercise. Glimepiride helps the pancreas release more insulin, Metformin reduces glucose production from the liver and improves insulin sensitivity, and Voglibose slows down glucose absorption after meals.
Common side effects of Glimison-VM 2 Tablet SR may include hypoglycemia (low blood sugar), nausea, diarrhea, changes in taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. Reporting any unusual or concerning symptoms is essential to ensure appropriate medical attention.
Individuals with known allergies to the medicine's components or excipients, including Glimepiride, Metformin, and Voglibose, should avoid using this medication. Additionally, individuals with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis should not take this medicine.
No, combining Glimison-VM 2 Tablet SR with alcohol is discouraged. Alcohol consumption can lower blood sugar levels (hypoglycemia) and may increase the risk of lactic acidosis.
Yes, Glimison-VM 2 Tablet SR can lead to hypoglycemia (low blood sugar levels). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, a rapid heartbeat, and feelings of anxiety or shakiness. It's more likely when missing meals, drinking alcohol, overexerting yourself, or taking other antidiabetic medications simultaneously. Regular blood sugar monitoring is crucial.
Store Glimison-VM 2 Tablet SR in its original packaging, tightly closed. Refer to the label or instructions on the medication pack for specific storage guidance. Do not consume expired medicine, and make sure it is inaccessible to pets, children, or others.